Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma

Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma

Item
http://www.wikidata.org/entity/Q36303796
Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesisHigh expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinomaPotential biomarkers associated with diabetic glomerulopathy through proteomics.Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate.Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.Aldo-keto reductase family 1 member B10 is associated with hepatitis B virus-related hepatocellular carcinoma risk.Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.Genomic variants link to hepatitis C racial disparities.Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma.Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy ReactionIntegrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma
P2860

Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma

Item
http://www.wikidata.org/entity/Q36303796
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@ast
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
type
label
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@ast
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
prefLabel
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@ast
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Up-regulated aldo-keto reducta ...... n and hepatocellular carcinoma
@en
P2093
P2860
P304
P31
P356
10.1111/J.1478-3231.2012.02827.X
P433
P478
P577
P5875
P698
P932